Neurocysticercosis in California: Clinical Characteristics and Associated Comorbidities Across the University of California Health System
This cross-sectional study of the University of California Health System reveals that neurocysticercosis, which disproportionately affects Hispanic/Latino patients with socioeconomic barriers, is strongly associated with epilepsy and a broad spectrum of neuropsychiatric comorbidities, underscoring the need for greater recognition of this disease in non-endemic U.S. settings.
Original paper licensed under CC BY 4.0 (https://creativecommons.org/licenses/by/4.0/). This is an AI-generated explanation of a preprint that has not been peer-reviewed. It is not medical advice. Do not make health decisions based on this content. Read full disclaimer
Neurocysticercosis is an infection of the brain caused by the larvae of a tapeworm called Taenia solium. People usually become infected by eating food or water contaminated with the eggs of this parasite, which are shed in the feces of someone carrying the adult tapeworm. Once inside the body, the eggs hatch, and the larvae travel through the bloodstream to various tissues, where they form cysts. When these cysts develop in the central nervous system, including the brain and spinal cord, the condition is known as neurocysticercosis. While this disease is a leading cause of acquired epilepsy in many parts of the world, particularly in Latin America, Africa, and Asia, it is often considered rare in the United States. However, because the U.S. has large populations of immigrants and travelers from regions where the parasite is common, the disease likely exists here more frequently than official records suggest, yet it often goes undiagnosed or unrecognized by healthcare providers.
A team of researchers set out to understand the true scope of this hidden burden within California by examining medical records from the entire University of California health system. This massive network includes six different medical centers across the state, serving a diverse population of over 11 million people. The team sifted through electronic health records spanning fourteen years, from 2012 to early 2026, looking for any patient diagnosed with neurocysticercosis. They identified 713 individuals with the condition. To put these cases into perspective, the researchers compared them with a much larger group of patients from the same hospitals who did not have the infection, matching them by age and location to ensure a fair comparison. This approach allowed them to see not just how common the disease was, but also what other health problems tended to appear alongside it.
The study revealed that neurocysticercosis is far from a rare curiosity in California; it affects approximately 6 out of every 100,000 patients within this health system. The people diagnosed with the infection were not a random cross-section of the population. They were significantly more likely to be Hispanic or Latino, to speak Spanish as their primary language, and to rely on Medicaid for health insurance. They also tended to live in neighborhoods with higher levels of economic disadvantage. These findings suggest that the disease disproportionately impacts communities that already face significant barriers to healthcare, such as language differences and limited access to specialized medical services.
Perhaps the most striking discovery was the wide range of other health conditions that appeared alongside the infection. The researchers found that patients with neurocysticercosis were far more likely to suffer from epilepsy, with the odds of having seizures being nearly twenty times higher than in people without the infection. But the connection did not stop there. The study showed strong links between the parasite and a broad spectrum of neurological and psychiatric issues, including migraines, cognitive impairment, mood disorders, strokes, and sleep disorders. Even conditions like Parkinson's disease and substance use disorders were more common in the infected group. This suggests that the damage caused by the parasite extends well beyond just causing seizures, creating a complex web of health challenges for those affected.
When the researchers adjusted their analysis to account for factors like age, gender, and socioeconomic status, the link between the infection and epilepsy remained incredibly strong. This indicates that the infection itself is a primary driver of the seizures, rather than the association being a result of other underlying social or demographic factors. Interestingly, the study also found that male patients with the infection had a slightly higher risk of developing epilepsy compared to females. While the study could not prove that the infection caused the other conditions in a direct, step-by-step timeline, the sheer strength of these associations points to a heavy burden of disease that is often overlooked in non-endemic settings like the United States.
The authors emphasize that these numbers likely represent only the tip of the iceberg. Because the study relied on diagnosed cases found in hospital records, it probably missed many people who have the infection but have never been tested or treated, particularly those who face the greatest barriers to care. The findings serve as a call to action for doctors and public health officials to keep a higher level of suspicion for this parasite, especially when treating patients who have traveled to or come from regions where the tapeworm is common. Recognizing neurocysticercosis earlier could mean the difference between managing a treatable infection and dealing with lifelong, debilitating neurological complications.
Drowning in papers in your field?
Get daily digests of the most novel papers matching your research keywords — with technical summaries, in your language.